MDC Publications

 

Publications in 2021 - 2022 (Last updated: Jan 2022)

  1. Samotus O, Parrent A, Jog M. Spinal cord stimulation therapy for gait dysfunction in progressive supranuclear palsy patients. J Neurol. 2021 Mar;268(3):989-996. doi: 10.1007/s00415-020-10233-7. Epub 2020 Oct 3. PMID: 33011852.
  2. Samotus O, Parrent A, Jog M. Spinal Cord Stimulation Therapy for Gait Dysfunction in Two Corticobasal Syndrome Patients. Can J Neurol Sci. 2021 Mar;48(2):278-280. doi: 10.1017/cjn.2020.143. Epub 2020 Jul 10. PMID: 32646537.
  3. Fishman KN, Roberts AC, Orange JB, Sunderland KM, Marras C, Tan B, Steeves T, Kwan D, Lang AE, Grimes D, Levine B, Masellis M, Binns MA, Jog M, Strother SC, Investigators O, McLaughlin PM, Troyer AK. Bilingualism in Parkinson's disease: Relationship to cognition and quality of life. J Clin Exp Neuropsychol. 2021 Mar;43(2):199-212. doi: 10.1080/13803395.2021.1902946. Epub 2021 Apr 8. PMID: 33827353.
  4. Ganguly J, Kulshreshtha D, Almotiri M, Jog M. Muscle Tone Physiology and Abnormalities. Toxins (Basel). 2021 Apr 16;13(4):282. doi: 10.3390/toxins13040282. PMID: 33923397; PMCID: PMC8071570.
  5. Samotus O, Lee J, Jog M. Developing a Consistent, Reproducible Botulinum Toxin Type A Dosing Method for Upper Limb Tremor by Kinematic Analysis. Toxins (Basel). 2021 Apr 8;13(4):264. doi: 10.3390/toxins13040264. PMID: 33917695; PMCID: PMC8067976.
  6. Kulshreshtha D, Ganguly J, Jog M. Manganese and Movement Disorders: A Review. J Mov Disord. 2021 May;14(2):93-102. doi: 10.14802/jmd.20123. Epub 2021 Apr 6. PMID: 33819420; PMCID: PMC8175808.
  7. Shahtalebi S, Atashzar SF, Patel RV, Jog MS, Mohammadi A. A deep explainable artificial intelligent framework for neurological disorders discrimination. Sci Rep. 2021 May 5;11(1):9630. doi: 10.1038/s41598-021-88919-9. PMID: 33953261; PMCID: PMC8099874.
  8. Ganguly J, Chai JR, Jog M. Minipolymyoclonus: A Critical Appraisal. J Mov Disord. 2021 May;14(2):114-118. doi: 10.14802/jmd.20166. Epub 2021 May 26. PMID: 34062647; PMCID: PMC8175814.
  9. Page AD, Elhayek N, Baylor C, Adams S, Jog M, Yorkston K. Exploring the Psychosocial Impact of Botulinum Toxin Type A Injections for Individuals With Oromandibular Dystonia: A Qualitative Study of Patients' Experiences. Am J Speech Lang Pathol. 2021 Jun 18;30(3S):1314-1328. doi: 10.1044/2020_AJSLP-20-00124. Epub 2021 Feb 25. PMID: 33647215.
  10. Senthinathan A, Adams S, Page AD, Jog M. Speech Intensity Response to Altered Intensity Feedback in Individuals With Parkinson's Disease. J Speech Lang Hear Res. 2021 Jun 18;64(6S):2261-2275. doi: 10.1044/2021_JSLHR-20-00278. Epub 2021 Apr 8. PMID: 33830820.
  11. Ganguly J, Kulshreshtha D, Jog M. Mercury and Movement Disorders: The Toxic Legacy Continues. Can J Neurol Sci. 2021 Jun 24:1-9. doi: 10.1017/cjn.2021.146. Epub ahead of print. PMID: 34346303.
  12. Kulshreshtha D, Pieterman M, Gilmore G, Jog M. Optimizing the selection of Parkinson's disease patients for neuromodulation using the levodopa challenge test. J Neurol. 2021 Jun 30. doi: 10.1007/s00415-021-10666-8. Epub ahead of print. PMID: 34191078.
  13. Knowles T, Adams SG, Jog M. Variation in Speech Intelligibility Ratings as a Function of Speech Rate Modification in Parkinson's Disease. J Speech Lang Hear Res. 2021 Jun 4;64(6):1773-1793. doi: 10.1044/2021_JSLHR-20-00593. Epub 2021 May 17. PMID: 33950711.
  14. Bernardinis M, Atashzar SF, Patel RV, Jog MS. Abnormal Vision-Based Displacement Perception in Parkinson's Disease. Front Neurosci. 2021 Jul 26;15:676469. doi: 10.3389/fnins.2021.676469. PMID: 34393703; PMCID: PMC8359811.
  15. Dilliott AA, Sunderland KM, McLaughlin PM, Roberts AC, Evans EC, Abrahao A, Binns MA, Black SE, Borrie M, Casaubon LK, Dowlatshahi D, Finger E, Fischer CE, Frank A, Freedman M, Grimes D, Hassan A, Jog M, Kumar S, Kwan D, Lang AE, Mandzia J, Marras C, Masellis M, McIntyre AD, Pasternak S, Pollock BG, Rajji TK, Robinson JF, Rogaeva E, Sahlas DJ, Saposnik G, Sato C, Seitz D, Shoesmith C, Steeves T, Strother SC, Swartz RH, Tan B, Tang-Wai D, Tartaglia MC, Troyer AK, Turnbull J, Zinman L; ONDRI Investigators, Hegele RA. Association of apolipoprotein E variation with cognitive impairment across multiple neurodegenerative diagnoses. Neurobiol Aging. 2021 Sep;105:378.e1-378.e9. doi: 10.1016/j.neurobiolaging.2021.04.011. Epub 2021 Apr 24. PMID: 34039480.
  16. Kumar N, Murgai AA, Jog M. Sensory Trick in Painful Legs and Moving Toes Syndrome. Neurol India. 2021 Sep-Oct;69(5):1436-1437. doi: 10.4103/0028-3886.329607. PMID: 34747836.
  17. Dilliott AA, Abdelhady A, Sunderland KM, Farhan SMK, Abrahao A, Binns MA, Black SE, Borrie M, Casaubon LK, Dowlatshahi D, Finger E, Fischer CE, Frank A, Freedman M, Grimes D, Hassan A, Jog M, Kumar S, Kwan D, Lang AE, Mandzia J, Masellis M, McIntyre AD, Pasternak SH, Pollock BG, Rajji TK, Rogaeva E, Sahlas DJ, Saposnik G, Sato C, Seitz D, Shoesmith C, Steeves TDL, Swartz RH, Tan B, Tang-Wai DF, Tartaglia MC, Turnbull J, Zinman L; ONDRI Investigators, Hegele RA. Contribution of rare variant associations to neurodegenerative disease presentation. NPJ Genom Med. 2021 Sep 28;6(1):80. doi: 10.1038/s41525-021-00243-3. PMID: 34584092; PMCID: PMC8478934.
  18. Samotus O, Chen R, Jog M. Changes in Cortical Excitability and Parkinson Tremor After Botulinum Toxin Therapy. Neurology. 2021 Sep 8:10.1212/WNL.0000000000012662. doi: 10.1212/WNL.0000000000012662. Epub ahead of print. PMID: 34497068.
  19. Knowles T, Adams SG, Jog M. Speech Rate Mediated Vowel and Stop Voicing Distinctiveness in Parkinson's Disease. J Speech Lang Hear Res. 2021 Nov 8;64(11):4096-4123. doi: 10.1044/2021_JSLHR-21-00160. Epub 2021 Sep 28. PMID: 34582276.
  20. Jain J, Son M, Debicki DB, Jog M, Casserly CS, Burneo JG, Budhram A. Epilepsia partialis continua in relapsing-remitting multiple sclerosis: A possible distinct relapse phenotype. Clin Neurol Neurosurg. 2021 Dec 21;213:107099. doi: 10.1016/j.clineuro.2021.107099. Epub ahead of print. PMID: 34959105.
  21. Sharma S, Sethi SK, Reese D, Gharabaghi S, Yerramsetty KK, Palutla VK, Chen Y, Haacke EM, Jog MS. Brain iron deposition and movement disorders in hereditary haemochromatosis without liver failure: A cross-sectional study. Eur J Neurol. 2022 Jan 6. doi: 10.1111/ene.15242. Epub ahead of print. PMID: 34989476.
  22. Ganguly J, Tuesta Bernaola M, Jog M. Role of Vitamins in Advanced Therapy for Parkinson's Disease: Decoding the Paradox. Can J Neurol Sci. 2022 Jan;49(1):3-4. doi: 10.1017/cjn.2021.106. Epub 2021 May 14. PMID: 33988104.